Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy.
AUTOR(ES)
Perrot, B
RESUMO
Sudden death was recorded by continuous ambulatory electrocardiographic (Holter) monitoring in a 62 year old man with hypertrophic cardiomyopathy and atrial fibrillation, who had been treated for four days with verapamil 360 mg orally. Analysis of the tape showed a third degree atrioventricular block followed by complete asystole. The sudden death could be related to treatment with verapamil.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=481511Documentos Relacionados
- Prediction of sudden death in hypertrophic cardiomyopathy
- Effects of verapamil on haemodynamic function and myocardial metabolism in patients with hypertrophic cardiomyopathy.
- Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.
- Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass.
- Hypertrophic cardiomyopathy associated with sudden death during marathon racing.
